Expansions in the US and Europe are included in a €1.5 billion investment plan ...

In the evolving landscape of pharmaceutical development, modified release (MR) tablets have emerged as a cornerstone technology for improving therapeutic outcomes and patient compliance. Unlike ...

Eli Lilly and Company has chosen the Lehigh Valley in Pennsylvania for its next manufacturing site in a $3.5 billion ...

Ardena has completed the process of divesting its active pharmaceutical ingredient (API) site in Södertälje, Sweden, to Nanologica AB.

Merz Therapeutics has appointed Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Staner will ...

Libris Innovations, the for-profit subsidiary of the Indiana Biosciences Research Institute (IBRI), has appointed Ramani ...

Veeva Systems has announced Veeva eSource, a new Veeva SiteVault application designed to streamline the flow of clinical ...

Vetter, a pharmaceutical service provider for the production of injectable drugs, has announced plans to build a new ...

Opentrons Labworks has made public its promotion of James Atwood to the position of Chief Executive Officer. In announcing ...

WuXi Biologics and Sinorda Biomedicine have jointly announced a strategic collaboration for the development and manufacturing of SND006.

Cell and gene therapies (CGTs) are revolutionizing treatment, but increasing regulatory scrutiny has led to a rise in costly ...

Halozyme has acquired Surf Bio for an upfront payment of $300 million, subject to customary purchase price adjustments, and up to $100 million milestone payments based on product development and ...